Carcinoid Tumor clinical trials at UCSF

• Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

  open to eligible people ages 18 years and up

  This randomized phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that have spread to other places in the body (advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.

  San Francisco, California and other locations

• Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

  Sorry, in progress, not accepting new patients

  This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, spreading, or getting worse. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

  San Francisco, California and other locations

Last updated: July 8, 2021